GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Total Liabilities

PeptiDream (PeptiDream) Total Liabilities : $197.9 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PeptiDream Total Liabilities?

PeptiDream's Total Liabilities for the quarter that ended in Mar. 2024 was $197.9 Mil.

PeptiDream's quarterly Total Liabilities increased from Sep. 2023 ($193.73 Mil) to Dec. 2023 ($202.21 Mil) but then declined from Dec. 2023 ($202.21 Mil) to Mar. 2024 ($197.92 Mil).

PeptiDream's annual Total Liabilities increased from Dec. 2021 ($14.80 Mil) to Dec. 2022 ($235.88 Mil) but then declined from Dec. 2022 ($235.88 Mil) to Dec. 2023 ($202.21 Mil).

PeptiDream Total Liabilities Historical Data

The historical data trend for PeptiDream's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeptiDream Total Liabilities Chart

PeptiDream Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.98 48.65 14.80 235.88 202.21

PeptiDream Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.22 188.77 193.73 202.21 197.92

PeptiDream Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PeptiDream's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=59.849+(136.368+5.314
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.678)
=202.2

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=482.451-280.242
=202.2

PeptiDream's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=67.418+(126.731+3.12
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.653)
=197.9

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=464.81-266.888
=197.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Total Liabilities Related Terms

Thank you for viewing the detailed overview of PeptiDream's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PeptiDream (PeptiDream) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PeptiDream Inc (OTCPK:PPTDF) » Definitions » Total Liabilities
Comparable Companies
TSE:4974 TSE:4565 TSE:2160 TSE:4599 TSE:4880 TSE:4592 TSE:7096 TSE:7774 TSE:4978 TSE:4893 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
4587:Japan
Address
1-2-10, Nihonbashi, Chuo-ku, Toyo Building, 6th Floor, Tokyo, JPN, 103-0027
Website
http://www.peptidream.com
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.